Compounds > arsenic
Page last updated: 2024-08-26

arsenic and rhodamine 123

arsenic has been researched along with rhodamine 123 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Small, PL; Snyder, DS1
Gao, F; Li, H; Shi, G; Shi, X; Tang, X; Yi, J1
Acalovschi, M; Aldea, M; Fischer-Fodor, E; Irimie, A; Kacso, G; Mosteanu, O; Petrushev, B; Pop, T; Soritau, O; Susman, S; Tomuleasa, C1

Other Studies

3 other study(ies) available for arsenic and rhodamine 123

ArticleYear
Staining of cellular mitochondria with LDS-751.
    Journal of immunological methods, 2001, Nov-01, Volume: 257, Issue:1-2

    Topics: Animals; Arsenicals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line; Digitonin; Fluorescent Dyes; Membrane Potentials; Mice; Microscopy, Confocal; Mitochondria; Monocytes; Organic Chemicals; Rhodamine 123; Staining and Labeling

2001
Apoptosis susceptibility of tumor cells to arsenic trioxide and the inherent cellular level of reactive oxygen species.
    Chinese medical journal, 2002, Volume: 115, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; DNA, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Oxides; Reactive Oxygen Species; Rhodamine 123; Tumor Cells, Cultured

2002
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
    Hematology/oncology and stem cell therapy, 2011, Volume: 4, Issue:2

    Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Capecitabine; Carcinoma, Hepatocellular; Cell Line; Cisplatin; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Glycoproteins; Hep G2 Cells; Humans; Immunohistochemistry; Interferon-alpha; Liver Neoplasms; Oxides; Peptides; Rhodamine 123; Thy-1 Antigens

2011